Prem Watsa RVNC Holdings History
Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-17,772.72
% of Total Estimate Gain
-19.35%
Prem Watsa's Revance Therapeutics Inc Holding Summary
As of 2025-03-31, Fairfax Financial Holdings held - shares of Revance Therapeutics Inc(RVNC), totaling N/A. This investment constitutes 0% of their stock portfolio, and Fairfax Financial Holdings now holds 0% of the outstanding Revance Therapeutics Inc(RVNC) stock.
The initial trade took place in 2024Q4. And since then Prem Watsa has made 1 purchases of RVNC, at an average price of $4.34, for a total of 21,158.00 shares. In addition, there have been 1 sales at an average price of $3.50 for 21,158.00 shares. Based on historical transaction data and RVNC's current price of $3.65, Prem Watsa's estimated gain on his RVNC holdings is $-17,772.72, reflecting a -19.35% gain to date.
Prem Watsa RVNC ($3.65) Holding Chart
Prem Watsa RVNC ($3.65) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1